Overview
Ke Zhou practices practicing medicine in Chengdu, China.
His clinical expertise encompasses Mediastinitis, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ke Zhou
Is Ke Zhou a top-rated expert for Mediastinitis?
MediFind is an objective health platform that identifies experts based on real-world data. Ke Zhou is classified as an Experienced expert for Mediastinitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ke Zhou participate in research or clinical trials?
Yes. Ke Zhou has published 8 articles and abstracts on conditions like Mediastinitis. You can view a list of Ke Zhou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMr. Zhou isExperienced. Learn about Lung Cancer.
- MediastinitisMr. Zhou isExperienced. Learn about Mediastinitis.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Zhou isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Mr. Zhou isExperienced. Learn about Small Cell Lung Cancer (SCLC).